Public South Korean biotech enterprise Macrogen, the nation’s main gene sequencing service supplier, is growing a genomic large information blockchain-based platform along with native tech agency Bigster, in accordance to an August 6 press release.
The new partnership will leverage blockchain tech to create a medical large information ecosystem that might permit for each the safe and personal storage and the switch of huge quantities of delicate genomic and private info.
As the press launch notes, advances in genomics are reshaping the worldwide medical panorama, permitting for individually custom-made diagnoses, remedy and prevention. Medical large information, which integrates people’ genomic, well being and way of life info, is each extremely delicate and of remarkable worth for the pharmaceutical and healthcare industries.
Speaking to native information outlet The Korea Herald, Macrogen CEO Yang Kap-seok commented,
“Despite its wide utility, gene data has been difficult to move around due to privacy protection issues and technological barriers. We hope that our upcoming blockchain-based platform will allow health care genet[ic] and medical big data to be circulated freely.”
Macrogen and Bigster goal to develop the platform by June 2019, and have opted to create a permissioned blockchain that might limit entry to particular establishments similar to pharmaceutical corporations, biotech corporations, hospitals, and analysis institutes.
As Cointelegraph reported this May, a precedent for using blockchain for the safe trade of genomic information has been set by American Nebula Genomics’ cooperation with Longenesis — the latter being a Hong-Kong-based partnership between Insilico Medicine and the Bitfury Group.
In April, US healthcare large UnitedHealth Group announced it might be implementing blockchain to hold its data up to date in a extra environment friendly, safe and accessible method.